Physician profile
Aleisha Richell Skiff
NPI 1932919644
$896.32
in general payments reported to CMS, 2019-2025
13 companies · $896 in 2025
The $896 reported for 2025 was more than what 85% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $316.57 | 2025 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $179.27 | 2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $116.11 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $61.30 | 2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.14 | 2025 | Xifaxan |
| Abbvie INC. | $34.79 | 2025 | |
| Amgen INC. | $29.76 | 2025 | Krystexxa, Evenity |
| Sumitomo Pharma America, INC. | $22.07 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $18.65 | 2025 | Verquvo |
| Agepha Pharma Fz LLC | $17.76 | 2025 | Lodoco |
| Edwards Lifesciences Corporation | $16.20 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $16.12 | 2025 | |
| Amneal Pharmaceuticals LLC | $13.58 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleisha Skiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.